Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis

References

• Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 2002;16:779–90.
   PubMed Web of Science ®Google Scholar
• Devergne 0, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996;70: 1143–53.
   Google Scholar
• Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, et al. WSX-1 and glycoprotein 130 constitute a signal-transduc-ing receptor for IL-27. J Immunol. 2004;172:2225–31.
   PubMed Web of Science ®Google Scholar
• Artis D, Villarino A, Silverman M, He W, Thornton EM, Mu S, et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol. 2004;173:5626–34.
   PubMed Web of Science ®Google Scholar
• Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. IL-27 and IFN-alpha signal via Statl and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res. 2003;23:513–22.
   Google Scholar
• Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial 'Thl commitment. J Immunol. 2003;170:4886–90.
   PubMed Web of Science ®Google Scholar
• Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A, et al. Development of Thl-type immune responses requires the type I cytokine receptor TCCR. Nature. 2000;407:916–20.
   PubMed Web of Science ®Google Scholar
• Takeda A, Hamano S, Shiraishi H, Yoshimura T, Ogata H, Ishii K, et al. WSX-1 over-expression in CD4(+) T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation. Int Immunol. 2005;17:889–97.
   PubMedGoogle Scholar
• Yoshida H, Hamano S, Senaldi G, Covey T, Faggioni R, Mu S, et al. WSX-1 is required for the initiation of Thl responses and resistance to L. major infection. Immunity. 2001;15:569–78.
   Google Scholar
• Lucas S, Ghilardi N, Li J, de Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4± T cells through Statl-dependent and -independent mechanisms. Proc Natl Acad Sci USA. 2003;100: 15047–52.
   Google Scholar
• Miyazaki Y, Inoue H, Matsumura M, Matsumoto K, Nakano T, Tsuda M, et al. Exacerbation of experimental allergic asthma by augmented 'Th2 responses in WSX-1-deficient mice. J Immunol. 2005;175:2401–7.
   PubMed Web of Science ®Google Scholar
• Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity. 2003;19:645–55.
   PubMed Web of Science ®Google Scholar
• Dixon FJ. The pathogenesis of glomerulonephritis. Am J Med. 1968;44:493–8.
   PubMed Web of Science ®Google Scholar
• Churg J BJ, Glassock RJ. Renal disease: Classification and atlas of glomerular disease. In: Churg J, Bernstein J, Glassock RJ, editors. Tokyo: Igaku-Shoin; 1995. p. 151–6.
   Google Scholar
• Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, et al. Predominance of Thl immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 2001;44: 2097–106.
   PubMed Web of Science ®Google Scholar
• Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E, et al. 'Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 1999;42:1644–8.
   PubMed Web of Science ®Google Scholar
• Van Parijs L, Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol. 1996;8:355–61.
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Sugiyama N, Masutani K, Sadanaga A, Miyazaki Y, Inoue Y, et al. Membranous glomerulonephritis development with Th2-type immune deviations in MRL//pr mice deficient for IL-27 receptor (WSX-1). J Immunol. 2005;175:7185–92.
   PubMed Web of Science ®Google Scholar
• Sugiyama N, Nakashima H, Yoshimura T, Sadanaga A, Shimizu S, Masutani K, et al. Amelioration of human lupus-like pheno-types in MRL//pr mice by overexpression of IL-2712{ alpha} (WSX-1). Ann Rheum Dis. 2007. (Epub ahead of print).
   Google Scholar
• Woodrow DF, Shore I, Moss J, Gower P, Phillips M. Immuno-electron microscopic studies of immune complex deposits and basement membrane components in IgA nephropathy. J Pathol. 1989;157:47–57.
   Google Scholar
• Cohen PL, Eisenberg RA. Lpr and gld: single-gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243–69.
   PubMed Web of Science ®Google Scholar
• Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of 'Th17 cells. Eur J Immunol. 2007;37:3021–9.
   PubMed Web of Science ®Google Scholar
• Hoffman RW, Alspaugh MA, Waggie KS, Durham JB, Walker SE. Sjögren's syndrome in MRL/1 and MRL/n mice. Arthritis Rheum. 1984;27: 157–65.
   Google Scholar
• Jonsson R, Tarkowski A, Backman K, Holmdahl R, Klareskog L. Sialadenitis in the MRL-1 mouse: morphological and immuno-histochemical characterization of resident and infiltrating cells. Immunology. 1987;60: 611–6.
   Google Scholar
• Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Te-rada M, et al. Antagonist of interferon-inducible protein 10/ CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL//pr mice. Arthritis Rheum. 2006;54: 1174–83.
   Google Scholar
• Yanagi K, Haneji N, Hamano H, Takahashi M, Higashiyama H, Hayashi Y. In vivo role of IL-10 and -12 during development of Sjögren's syndrome in MRL//pr mice. Cell Immunol. 1996;168:243–50.
   PubMedGoogle Scholar
• Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol. 1994;152:5532–9.
   Google Scholar
• Ohyama Y, Nakamura S, Matsuzaki G, Shinohara M, Hiroki A, Fujimura T, et al. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 1996;39:1376–84.
   PubMed Web of Science ®Google Scholar
• Konttinen YT, Kemppinen P, Koski H, Li TF, Jumppanen M, Hietanen J, et al. T(H)1 cytokines are produced in labial salivary glands in Sjögren's syndrome, but also in healthy individuals. Scand J Rheumatol. 1999;28:106–12.
   PubMed Web of Science ®Google Scholar
• Price EJ, Venables PJ. The etiopathogenesis of Sjögren's syn-drome. Semin Arthritis Rheum. 1995;25:117–33.
   PubMedGoogle Scholar
• Ozaki Y, Amakawa R, Ito T, Iwai H, Tajima K, Uehira K, et al. Alteration of peripheral blood dendritic cells in patients with primary Sjögren's syndrome. Arthritis Rheum. 2001;44:419–31.
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with scle-rosing pancreatitis. N Engl J Med. 2001;344:732–8.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683–7.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoim-mune disease. J Gastroenterol. 2003;38:982–4.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N. Autoim-mune pancreatitis metachronously associated with retroperitoneal fibrosis with IgG4-positive plasma cell infiltration. World J Gastroenterol. 2006;12: 2955–7.
   Google Scholar
• Kitagawa S, Zen Y, Harada K, Sasaki M, Sato Y, Minato H, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am J Surg Pathol. 2005;29:783–91.
   PubMed Web of Science ®Google Scholar
• Zen Y, Kasahara Y, Horita K, Miyayama S, Miura S, Kitagawa S, et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pan-creatitis. Am J Surg Pathol. 2005;29:275–8.
   PubMed Web of Science ®Google Scholar
• Zen Y, Sawazaki A, Miyayama S, Notsumata K, Tanaka N, Nakanuma Y. A case of retroperitoneal and mediastinal fibrosis exhibiting elevated levels of IgG4 in the absence of sclerosing pancreatitis (autoimmune pancreatitis). Hum Pathol. 2006;37: 239–43.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheuma-tology (Oxford). 2005;44:227–34.
   PubMed Web of Science ®Google Scholar
• Morgan WS, Castleman B. A clinicopathologic study of Miku-licz's disease. Am J Pathol. 1953;29:471–503.
   PubMed Web of Science ®Google Scholar
• Zhang K, Mills FC, Saxon A. Switch circles from IL-4-directed epsilon class switching from human B lymphocytes. Evidence for direct, sequential, and multiple step sequential switch from mu to epsilon Ig heavy chain gene. J Immunol. 1994;152: 3427–35.
   Google Scholar
• Agresti A, Vercelli D. Analysis of gamma4 germline transcrip-tion in human B cells. Int Arch Allergy Immunol. 1999;118:279–81.
   PubMed Web of Science ®Google Scholar
• Miyake K, Moriyama M, Aizawa K, Nagano S, Inoue Y, Sadanaga A, et al. Peripheral CD4± T cells showing a 'Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol. 2008;18:86–90.
   PubMed Web of Science ®Google Scholar